Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Amy Feldman - Italy's $10 Billion Pharma Family Makes A U.S. Power Move
Italy's $10 Billion Pharma Family Makes A U.S. Power Move
Forbes

or more than 100 years, the billionaire Angelini family had been content to run a largely European business empire from their headquarters in Rome: pharmaceuticals like the Italian equivalent of Tylenol and the antidepressant trazodone, as well as…

globenewswire.com - Vistin Pharma ASA - Vistin Pharma ASA: Second quarter and YTD 2026 financial results
Vistin Pharma ASA: Second quarter and YTD 2026 financial results
GlobeNewswire

Vistin Pharma ASA (VISTN) today announces its financial results for the second quarter and first half of 2026. Revenue in the second quarter amounted to MNOK 100, compared to MNOK 118 in Q2 2025. Sales volume increased by 8%, offset by a…

thestandard.com.hk - Gloria Leung - Hang Seng climbs nearly 1 percent as pharma and gold stocks surge
Hang Seng climbs nearly 1 percent as pharma and gold stocks surge
The Standard

Hong Kong stocks closed higher on Thursday, broadly boosted by a surge in pharmaceutical and gold shares, while tech heavyweights posted mixed results. SCROLL TO CONTINUE WITH CONTENT The benchmark Hang Seng Index rose 231 points, or 0.91 percent…

thestandard.com.hk - The Standard 英文虎報 - HSI rose 291 points by midday as pharma and commodity shares rally, Kuaishou fell 9.74pc
HSI rose 291 points by midday as pharma and commodity shares rally, Kuaishou fell 9.74pc
The Standard

Hong Kong stocks sustained their upward momentum at noon on Thursday as biopharmaceutical and commodity shares gained further. SCROLL TO CONTINUE WITH CONTENT The benchmark Hang Seng Index rose 291 points, or 1.14 percent, to 25,786 points…

newswire.ca - Aurora Cannabis Inc. - Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
CNW

EDMONTON, AB, Aug. 19, 2026 /CNW/ -- Aurora Cannabis Inc. (the 'Company' or 'Aurora') (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a…

thehindubusinessline.com - Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical on two insulin analogues
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical on two insulin analogues
BusinessLine

Mankind Pharma has inked an exclusive in-licensing and marketing agreement with China 's Chongqing Chenan Biopharmaceutical Co Ltd, to commercialise two insulin analogues - Insulin Degludec and Insulin Degludec + Aspart Combination, in India. The…

marketbeat.com - Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to Strong-Buy at BMO Capital Markets
Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to Strong-Buy at BMO Capital Markets
MarketBeat

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) was upgraded by BMO Capital Markets to a 'strong-buy' rating in a note issued to investors on Tuesday, Marketbeat.com reports. Can BioMarin Stock Live Up to Wall Street's High Expectations? Other…

marketbeat.com - 30,000 Shares in Royalty Pharma PLC $RPRX Purchased by Monetta Financial Services Inc.
30,000 Shares in Royalty Pharma PLC $RPRX Purchased by Monetta Financial Services Inc.
MarketBeat

Monetta Financial Services Inc. acquired a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired…

forbes.com - Danielle Chemtob - Forbes Daily: Moderna Stock Surges On Landmark Cancer Vaccine Trial
Forbes Daily: Moderna Stock Surges On Landmark Cancer Vaccine Trial
Forbes

Moderna had its best trading day ever as the company reported positive results from a landmark cancer vaccine trial. The biotech giant's stock skyrocketed 177% Wednesday after Moderna and Merck reported that their vaccine helped reduce the…

forbes.com - Grace Chung - Why International Banking Hub Switzerland Is Also A Billionaire Haven
Why International Banking Hub Switzerland Is Also A Billionaire Haven
Forbes

S witzerland has long been a bastion of finance and fortune making, drawing investors and corporations from around the globe who are attracted to the Alpine country's political stability, economic strength—and attractive tax rates. In fact…

thehindu.com - The Hindu Bureau - Pendurthi MLA seeks rehabilitation of Thadi village at the earliest
Pendurthi MLA seeks rehabilitation of Thadi village at the earliest
The Hindu

Pendurthi MLA Panchakarla Ramesh Babu has urged the State government to take immediate steps to rehabilitate and relocate residents of Thadi village in Anakapalli district, citing safety concerns due to several pharmaceutical units in and around…

seekingalpha.com - Albert Anthony - Lowe's: The Retailer To Watch And Wait, Even As Q2 Results Saw Growth (Rating Downgrade)
Lowe's: The Retailer To Watch And Wait, Even As Q2 Results Saw Growth (Rating Downgrade)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

boredpanda.com - Viktorija Strelciunaite - 79 Random Bits Of Insider Knowledge From Different Industries To Change How You See The World
79 Random Bits Of Insider Knowledge From Different Industries To Change How You See The World
Bored Panda

Early childhood educators know everything about you and all your family members. EVERYTHING! I'm a retired Medical Lab Tech II from the Infusion Center at one of the largest hospitals in the country, and I learned that the human body's immune…

seekingalpha.com - High Alpha Professor - Travere Therapeutics: Valuation Suggests A Buy (NASDAQ:TVTX)
Travere Therapeutics: Valuation Suggests A Buy (NASDAQ:TVTX)
Seeking Alpha

Travere Therapeutics is rated Buy, with a DCF-based fair value of ~$81 per share, implying 27% upside. FILSPARI's commercial ramp is strong, posting $141.1M in Q2 U.S. sales and targeting a $3B+ peak sales opportunity across IgAN and FSGS. My model…

globenewswire.com - AC Immune SA - AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
GlobeNewswire

AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764 ACI-19764 is an orally available inhibitor of the NLRP3 inflammasome Preliminary data showed ACI-19764 was safe and well tolerated across single and multiple…

Receive a Daily briefing on Pharma Industry News

Get Started